Pricing Log in Create free account

NRx Pharmaceuticals, Inc. (NRXP) vs Unicycive Therapeutics, Inc. (UNCY)

NRx Pharmaceuticals, Inc. and Unicycive Therapeutics, Inc. are both Biotechnology companies. NRx Pharmaceuticals, Inc. and Unicycive Therapeutics, Inc. are of similar size ($98.3M and $96.9M). Unicycive Therapeutics, Inc. has the higher net margin (0.00% vs −691.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, NRx Pharmaceuticals, Inc. leads on 6 and Unicycive Therapeutics, Inc. on 6.

Valuation

Metric NRXP UNCY Biotechnology median
P/E n/m n/m 10.60
P/S 25.96 n/m 9.40
P/B n/m 1.78 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 19.69 n/m 9.02
Earnings yield (23.50%) (45.67%) (32.88%)
Free cash flow yield (23.46%) (29.31%) (23.13%)

Profitability

Metric NRXP UNCY Biotechnology median
Gross margin 46.64% 0.00% 68.51%
Operating margin (586.15%) 0.00% 0.00%
Net margin (691.78%) 0.00% 0.00%
Free cash flow margin (609.02%) 0.00% 0.00%
Return on equity 131.22% (101.07%) (51.96%)
Return on assets (120.41%) (69.05%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric NRXP UNCY Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 43.22% 70.18% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NRXP UNCY Biotechnology median
Debt to equity (2.42) 0.00 0.00
Current ratio 0.86 3.81 4.97
Net debt to EBITDA 0.48 1.43 1.01

Dividend

Metric NRXP UNCY Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric NRXP UNCY Biotechnology median
Market cap 98.28m 96.94m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack